CEO and co-founder of Alphanosos (France)

Pascal Mayer

Dr. Pascal Mayer, PhD, is a scientific innovator and inventor of various technologies with large market value. His inventions lead to the filing of 12 patent families including the core patents behind the world's leading sequencing technology (Illumina), and biofilm measurement technologies (Biofilm Control). He is the CEO of Alphanosos. Prior to Alphanosos, key experience included VP drug-discovery at BioFilm Control, CEO at Haploys, CSO at Manteia Predictive Medicine (a spin-off from Serono), and Scientist at Glaxo-Wellcome and later Serono.

PRINCIPAL ACADEMIC PARTNERS

MONT BLANC SUPPORTER

1/3

MATTERHORN SUPPORTERS